Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.

Issue 8, 2014
Previous Article Next Article

Manganese graft ionomer complexes (MaGICs) for dual imaging and chemotherapy

Author affiliations


Novel manganese graft ionomer complexes (MaGICs) that contain Mn ions complexed with a polyaminobisphosphonate-g-poly(ethylene oxide) (PEO) copolymer were developed for use as T1-weighted contrast agents for MRI. The complexes exhibited good colloidal stability without release of free manganese and did not result in any in vitro toxicity against mouse hepatocytes. T1 relaxivities of the MaGICs at physiological pH were 2–10 times higher than that of a commercial manganese-based positive contrast agent. Anticancer drugs including doxorubicin, cisplatin and carboplatin were successfully encapsulated into the MaGICs with high efficiency. Drug release behavior was sustained and depended on pH (faster in acidic environments), drug structures and drug concentration (faster with high concentration). The anticancer drug-loaded manganese nanocarriers exhibited excellent anticancer activity against MCF-7 breast cancer cells together with high relaxivity. Thus, these drug-loaded MaGICs could potentially be utilized for simultaneous diagnosis and treatment of cancer.

Graphical abstract: Manganese graft ionomer complexes (MaGICs) for dual imaging and chemotherapy

Back to tab navigation

Supplementary files

Article information

19 Sep 2013
07 Jan 2014
First published
09 Jan 2014

J. Mater. Chem. B, 2014,2, 1087-1099
Article type

Manganese graft ionomer complexes (MaGICs) for dual imaging and chemotherapy

N. Pothayee, N. Pothayee, N. Hu, R. Zhang, D. F. Kelly, A. P. Koretsky and J. S. Riffle, J. Mater. Chem. B, 2014, 2, 1087
DOI: 10.1039/C3TB21299H

Social activity

Search articles by author